Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05227144 |
Title | Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | ORIC Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
James R. Berenson, MD, Inc. | COMPLETED | West Hollywood | California | 90069 | United States | Details |
Northside Hospital Cancer Institute | RECRUITING | Atlanta | Georgia | 30342 | United States | Details |
Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
Mayo Clinical Rochester | RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
Icahn School of Medicine at Mount Sinai | RECRUITING | New York | New York | 10029 | United States | Details |
The Charlotte-Mecklenburg Hospital Authority d/b/a Atrium Health | RECRUITING | Charlotte | North Carolina | 28203 | United States | Details |
Swedish Health Services | RECRUITING | Seattle | Washington | 98107 | United States | Details |
Princess Margaret Cancer Research Center/University Health Network | RECRUITING | Toronto | Ontario | Canada | Details |